Pediatric ID and Immunization Updates

Resources for Pediatric ID and Immunization Updates for All Ages

 

Mission:  To provide healthcare professionals with timely, evidence-based insights into pediatric infectious diseases and immunization practices for all ages, with a special emphasis on pharmacist-specific considerations.


The University of Connecticut School of Pharmacy and the Pediatric Pharmacy Association (PPA) have partnered to advance pharmacist education and professional development in pediatric infectious diseases and immunization practices.

Leading this initiative is Jennifer Girotto, PharmD, BCPPS, BCIDP, Assistant Department Head and Clinical Professor of Pharmacy Practice at UConn. Board certified in both Pediatric Pharmacy and Infectious Diseases Pharmacy, she brings more than 20 years of experience as an educator and clinician specializing in pediatric infectious diseases and immunizations.

With a deep passion for teaching, Dr. Girotto mentors student writers and trainees in literature review and content development, helping to amplify their voices and prepare the next generation of pediatric pharmacy professionals.

The aim of this blog is to help pharmacists, along with other healthcare providers and trainees, stay informed about evolving topics in pediatric infectious diseases and immunization practices by sharing the most recent evidence-based information and insights

Slide summarizing pediatric treatment considerations for resistant Gram-positive infections, highlighting vancomycin’s continued role in invasive MRSA, susceptibility-guided therapy for MRSA and VRE, alternative agents, and pharmacist involvement in optimizing safety and step-down treatment.

Treatment of Gram-Positive Resistant Organisms in Children: Challenges and Current Strategies

By Kaitlyn Kenyon, PharmD Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE) aren’t just hospital buzzwords anymore — they’re among the leading drug-resistant pathogens gaining ground since the COVID-19 pandemic, turning once-routine infections into increasingly difficult treatment challenges and raising the stakes for antibiotic selection decisions in children.1 The Controversy of Vancomycin Vancomycin was discovered […]

[Read More]
Summary of Endocarditis Blog Post

Oral Antibiotic Transition for Pediatric Endocarditis: Is it Ready for Prime Time?

By Hira Ilyas, PharmD Dr. Pak and colleagues have recently published their early experience using intravenous to oral transition in pediatric endocarditis at Seattle Children’s hospital, which raises the question of whether this approach is ready for broader use.1,2 They reported on the use of intravenous to oral antibiotic transition in pediatric endocarditis from December […]

[Read More]
This image summarizes the key information in the associated blog post.

Resurgence of Lyme Disease: Key Insights for Pediatric Prophylaxis

Lyme Disease is being diagnosed earlier in the season and with increasing frequency. Diagnosed annual cases of Lyme Disease in the United States tripled from 2010 to 2023 (30,158 – 89,468).1 It is primarily concentrated in the Northeast and upper Midwest, with cases spanning from Maine through the Mid-Atlantic states and extending westward to Wisconsin.1 […]

[Read More]
Provides a summary of congenital syphilis blog article.

Congenital Syphilis Still an Issue, Pharmacotherapy Opportunities to Improve

Centers for Disease Control and Prevention (CDC) mentioned in September 2025, that congenital syphilis cases increased for the 12th consecutive year.1 This information, in combination with periodic shortages of Bicillin LA2, the primary treatment of syphilis in pregnancy, suggest it may not decrease soon. Why is Congenital Syphilis an Issue? Congenital syphilis is an issue […]

[Read More]
Summary of CAP blog

How Long Should We Treat Pediatric Outpatient CAP? Rethinking Antibiotic Duration

By Nicole Pietraszewski PharmD Candidate, Community acquired pneumonia (CAP) is the cause of about 1.5 million pediatric medical visits each year and remains the second-leading cause of pediatric hospitalizations in the United States.1 The 2011  Pediatric Infectious Disease Society and Infectious Diseases Society of America (PIDS/IDSA) guideline for pediatric CAP, currently archived, recommends a 10-day […]

[Read More]
Summary of blog post recommendations for intra-abdominal infections in pediatric patients.

Surgical Infection Society Pediatric Intra-Abdominal Infection – Antimicrobial Stewardhip Highlights

The Surgical Infection Society (SIS) Guidelines on the Prevention and Management of Pediatric Intra-Abdominal Infection Update was just published.1 These authors note that these are to be used in conjunction with the prior guidelines, as many aspects have not changed. Source control remains essential. For treatment they continue to recommend the combination of ceftriaxone (or […]

[Read More]
Summary highlights of measles blog post.

Measles is Back, What Should You Know?

Measles, a disease that was a rare occurrence in the recent past, has become much more common beginning in 2025. As I have received many questions about measles vaccine and treatment options, I thought it would be a good initial topic to discuss in early 2026. Measles Cases Continuing to Increase The incidence of measles […]

[Read More]
Summary of bacterial arthritis recommendations

Pediatric Bacterial Arthritis (Septic Arthritis): Takeaways for Pharmacy Practice (with additional data supporting oral therapy for some)

By Kenna Riley PharmD Candidate,   Bacterial arthritis (e.g., septic arthritis) is caused by bacteria entering the joint from the bloodstream, causing infection and inflammation of the joint and synovial fluid.​1​ It requires prompt antibiotic treatment to prevent severe outcomes, such as irreversible joint damage.  In 2023, the Pediatric Infectious Diseases Society (PIDS) and the […]

[Read More]

Disclaimer: The information provided on this website is intended for educational purposes only and is directed toward healthcare providers and educators. It does not constitute individualized medical advice, diagnosis, or treatment, and should not be used as a substitute for professional judgment in patient care. While every effort is made to ensure accuracy and currency, the authors and contributors make no representations or warranties regarding completeness or applicability. The views expressed are those of the authors and do not necessarily reflect the policies or positions of any affiliated institutions. By using this site, you acknowledge and agree that neither the authors nor the site are responsible for any decisions made based on the content provided.